For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and Attruby represents a significant advancement . These groundbreaking therapies protect the transthyretin protein, slowing its harmful build-up and reducing the burd